Inission - Strong Q3 with more to come
Orders +62% y-o-y, BTB ~1.5xStrength across segments, EBITA +15% vs. ABGSCeTrading at 13-10x '26e-'28e P/E vs. 17-12x Nordic EMS peersDisplaying broad...
Orders +62% y-o-y, BTB ~1.5xStrength across segments, EBITA +15% vs. ABGSCeTrading at 13-10x '26e-'28e P/E vs. 17-12x Nordic EMS peersDisplaying broad...
Soft autumn intake, implying EBITA flattish y-o-y, 7% below ABGOHN slightly better than guided, Sonans the soft spotStrong cost focusSoft autumn intak...
Q3 in line, loss narrows vs. Q2FDA open to SPARKLE reread, endpoint still undefinedBuilding blocks in place for the next phaseQ3 in line, loss narrows...
13% organic growth (cons 5%), EBITA +47% vs consSales beat in all regions, AI implementation deals develop strongly"Progressing towards 17% margin" (c...
Record-high order backlog of EUR 160mSales EUR 42.6m, adj. EBIT 1.0mTrading at 12-8x '27e-'28eQ3 resultsCavotec reported better Q3 results, improving ...
Q3 earnings miss, but restructuring supports earnings recoveryWe cut '27e-/'28e EBIT by 1.8%/10%Further operational improvements needed to drive growt...
Orders +62% y-o-y and +50% vs. ABGSCe for 1.5x b-t-bEBITA adj. of SEK 49m, +15% vs. ABGSCeBroad-based strength behind earnings beatQ3 resultsOrders we...